QUIDELORTHO CORP (QDEL)

US2197981051 - Common Stock

44.6  +0.02 (+0.04%)

After market: 44.6 0 (0%)

Fundamental Rating

3

Taking everything into account, QDEL scores 3 out of 10 in our fundamental rating. QDEL was compared to 187 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of QDEL while its profitability can be described as average. QDEL is valued correctly, but it does not seem to be growing.



5

1. Profitability

1.1 Basic Checks

In the past year QDEL was profitable.
In the past year QDEL had a positive cash flow from operations.
QDEL had positive earnings in 4 of the past 5 years.
QDEL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

QDEL's Return On Assets of -27.45% is in line compared to the rest of the industry. QDEL outperforms 46.52% of its industry peers.
The Return On Equity of QDEL (-58.57%) is comparable to the rest of the industry.
QDEL has a Return On Invested Capital of 1.34%. This is in the better half of the industry: QDEL outperforms 68.98% of its industry peers.
QDEL had an Average Return On Invested Capital over the past 3 years of 14.72%. This is significantly above the industry average of 8.19%.
The last Return On Invested Capital (1.34%) for QDEL is well below the 3 year average (14.72%), which needs to be investigated, but indicates that QDEL had better years and this may not be a problem.
Industry RankSector Rank
ROA -27.45%
ROE -58.57%
ROIC 1.34%
ROA(3y)11.68%
ROA(5y)17.27%
ROE(3y)15.81%
ROE(5y)24.25%
ROIC(3y)14.72%
ROIC(5y)21.16%

1.3 Margins

QDEL's Operating Margin of 3.68% is fine compared to the rest of the industry. QDEL outperforms 69.52% of its industry peers.
In the last couple of years the Operating Margin of QDEL has declined.
QDEL's Gross Margin of 47.62% is in line compared to the rest of the industry. QDEL outperforms 40.11% of its industry peers.
In the last couple of years the Gross Margin of QDEL has declined.
Industry RankSector Rank
OM 3.68%
PM (TTM) N/A
GM 47.62%
OM growth 3Y-49.14%
OM growth 5Y-16.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15%
GM growth 5Y-3.78%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so QDEL is still creating some value.
The number of shares outstanding for QDEL has been increased compared to 1 year ago.
QDEL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for QDEL has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.10, QDEL is in line with its industry, outperforming 47.06% of the companies in the same industry.
A Debt/Equity ratio of 0.68 indicates that QDEL is somewhat dependend on debt financing.
The Debt to Equity ratio of QDEL (0.68) is worse than 68.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACC0.16
WACC8.35%

2.3 Liquidity

A Current Ratio of 1.38 indicates that QDEL should not have too much problems paying its short term obligations.
With a Current ratio value of 1.38, QDEL is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
QDEL has a Quick Ratio of 1.38. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of QDEL (0.81) is worse than 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.81

3

3. Growth

3.1 Past

The earnings per share for QDEL have decreased strongly by -49.36% in the last year.
The Earnings Per Share has been growing slightly by 6.32% on average over the past years.
Looking at the last year, QDEL shows a decrease in Revenue. The Revenue has decreased by -9.74% in the last year.
QDEL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.83% yearly.
EPS 1Y (TTM)-49.36%
EPS 3Y-40.82%
EPS 5Y6.32%
EPS Q2Q%-5.56%
Revenue 1Y (TTM)-9.74%
Revenue growth 3Y21.74%
Revenue growth 5Y41.83%
Sales Q2Q%-2.27%

3.2 Future

QDEL is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.84% yearly.
QDEL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.87% yearly.
EPS Next Y-55.39%
EPS Next 2Y-21.82%
EPS Next 3Y-5.84%
EPS Next 5YN/A
Revenue Next Year-9.12%
Revenue Next 2Y-4.74%
Revenue Next 3Y-1.87%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

QDEL is valuated rather expensively with a Price/Earnings ratio of 18.66.
Compared to the rest of the industry, the Price/Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 88.24% of the companies listed in the same industry.
QDEL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.55, which is the current average of the S&P500 Index.
QDEL is valuated rather expensively with a Price/Forward Earnings ratio of 17.67.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 85.56% of the companies listed in the same industry.
QDEL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.00, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.66
Fwd PE 17.67

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QDEL indicates a rather cheap valuation: QDEL is cheaper than 95.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.6

4.3 Compensation for Growth

A cheap valuation may be justified as QDEL's earnings are expected to decrease with -5.84% in the coming years.
PEG (NY)N/A
PEG (5Y)2.95
EPS Next 2Y-21.82%
EPS Next 3Y-5.84%

0

5. Dividend

5.1 Amount

QDEL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

QUIDELORTHO CORP

NASDAQ:QDEL (12/26/2024, 4:37:23 PM)

After market: 44.6 0 (0%)

44.6

+0.02 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners85.58%
Inst Owner Change2.92%
Ins Owners0.55%
Ins Owner Change0.17%
Market Cap3.00B
Analysts74.29
Price Target54.91 (23.12%)
Short Float %5.9%
Short Ratio4.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)116.37%
Min EPS beat(2)70.58%
Max EPS beat(2)162.15%
EPS beat(4)3
Avg EPS beat(4)49.79%
Min EPS beat(4)-43.99%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)34.67%
EPS beat(12)9
Avg EPS beat(12)37.28%
EPS beat(16)11
Avg EPS beat(16)28.49%
Revenue beat(2)2
Avg Revenue beat(2)6.4%
Min Revenue beat(2)1.79%
Max Revenue beat(2)11.02%
Revenue beat(4)3
Avg Revenue beat(4)1.18%
Min Revenue beat(4)-8.64%
Max Revenue beat(4)11.02%
Revenue beat(8)7
Avg Revenue beat(8)3.13%
Revenue beat(12)10
Avg Revenue beat(12)3.67%
Revenue beat(16)11
Avg Revenue beat(16)4.11%
PT rev (1m)-4.15%
PT rev (3m)0.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-49.91%
EPS NY rev (1m)4.23%
EPS NY rev (3m)-70.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.94%
Revenue NY rev (1m)2.24%
Revenue NY rev (3m)-6.54%
Valuation
Industry RankSector Rank
PE 18.66
Fwd PE 17.67
P/S 1.06
P/FCF N/A
P/OCF 30.09
P/B 0.94
P/tB N/A
EV/EBITDA 9.6
EPS(TTM)2.39
EY5.36%
EPS(NY)2.52
Fwd EY5.66%
FCF(TTM)-1.44
FCFYN/A
OCF(TTM)1.48
OCFY3.32%
SpS41.89
BVpS47.38
TBVpS-5.65
PEG (NY)N/A
PEG (5Y)2.95
Profitability
Industry RankSector Rank
ROA -27.45%
ROE -58.57%
ROCE 1.8%
ROIC 1.34%
ROICexc 1.37%
ROICexgc 3.75%
OM 3.68%
PM (TTM) N/A
GM 47.62%
FCFM N/A
ROA(3y)11.68%
ROA(5y)17.27%
ROE(3y)15.81%
ROE(5y)24.25%
ROIC(3y)14.72%
ROIC(5y)21.16%
ROICexc(3y)21.88%
ROICexc(5y)30.45%
ROICexgc(3y)42.74%
ROICexgc(5y)59.07%
ROCE(3y)19.74%
ROCE(5y)28.37%
ROICexcg growth 3Y-59.79%
ROICexcg growth 5Y-37.21%
ROICexc growth 3Y-68%
ROICexc growth 5Y-28.82%
OM growth 3Y-49.14%
OM growth 5Y-16.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15%
GM growth 5Y-3.78%
F-Score3
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 3.86
Cap/Depr 42.76%
Cap/Sales 6.97%
Interest Coverage 250
Cash Conversion 17.7%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.81
Altman-Z 1.1
F-Score3
WACC8.35%
ROIC/WACC0.16
Cap/Depr(3y)211.17%
Cap/Depr(5y)163.64%
Cap/Sales(3y)9.51%
Cap/Sales(5y)7.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.36%
EPS 3Y-40.82%
EPS 5Y6.32%
EPS Q2Q%-5.56%
EPS Next Y-55.39%
EPS Next 2Y-21.82%
EPS Next 3Y-5.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.74%
Revenue growth 3Y21.74%
Revenue growth 5Y41.83%
Sales Q2Q%-2.27%
Revenue Next Year-9.12%
Revenue Next 2Y-4.74%
Revenue Next 3Y-1.87%
Revenue Next 5YN/A
EBIT growth 1Y-64.52%
EBIT growth 3Y-38.09%
EBIT growth 5Y18.04%
EBIT Next Year-5.03%
EBIT Next 3Y4.09%
EBIT Next 5YN/A
FCF growth 1Y-110.46%
FCF growth 3Y-49.93%
FCF growth 5Y-7.48%
OCF growth 1Y-90.39%
OCF growth 3Y-23.66%
OCF growth 5Y15.5%